These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6187504)
41. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Salvador G; Gomez A; Vinas O; Ercilla G; Canete JD; Munoz-Gomez J; Sanmarti R Rheumatology (Oxford); 2003 Aug; 42(8):972-5. PubMed ID: 12730510 [TBL] [Abstract][Full Text] [Related]
42. Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Youinou P; Le Goff P; Colaco CB; Thivolet J; Tater D; Viac J; Shipley M Ann Rheum Dis; 1985 Jul; 44(7):450-4. PubMed ID: 2411231 [TBL] [Abstract][Full Text] [Related]
43. Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Quismorio FP; Kaufman RL; Beardmore T; Mongan ES Arthritis Rheum; 1983 Apr; 26(4):494-9. PubMed ID: 6188470 [TBL] [Abstract][Full Text] [Related]
44. Inter-relationships of laboratory variables in rheumatoid arthritis. Haataja M; Kalliomaki JL J Rheumatol; 1978; 5(3):263-6. PubMed ID: 748550 [TBL] [Abstract][Full Text] [Related]
46. Antikeratin antibodies in rheumatoid arthritis. Methods and clinical significance. Kirstein H; Mathiesen FK Scand J Rheumatol; 1987; 16(5):331-8. PubMed ID: 2446384 [TBL] [Abstract][Full Text] [Related]
47. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. Berntzen HB; Munthe E; Fagerhol MK J Rheumatol; 1989 Nov; 16(11):1416-20. PubMed ID: 2600939 [TBL] [Abstract][Full Text] [Related]
49. Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity. Gerber DA J Clin Invest; 1975 Jun; 55(6):1164-73. PubMed ID: 1079527 [TBL] [Abstract][Full Text] [Related]
50. [Antikeratin antibodies: another specific antibodies in rheumatoid arthritis patients]. Zhou Z; Jiang M; Wang H Zhonghua Nei Ke Za Zhi; 1995 May; 34(5):330-2. PubMed ID: 8565719 [TBL] [Abstract][Full Text] [Related]
51. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255 [TBL] [Abstract][Full Text] [Related]
52. [Gm properties in rheumatoid diseases with special reference to chronic progressive polyarthritis. II. Anti-Gm factors n rheumatoid diseases]. Neumann W; Barthel E; Tanner E; Seidel K Z Gesamte Inn Med; 1970 Jun; 25(11):500-5. PubMed ID: 5523394 [No Abstract] [Full Text] [Related]
53. Anti-keratin antibodies in patients with juvenile idiopathic arthritis. Hromadníková I; Vavrincova P; Stechova K; Hridelova D Clin Exp Rheumatol; 2001; 19(4):470-3. PubMed ID: 11491508 [TBL] [Abstract][Full Text] [Related]
54. Clinical relevance of antikeratin antibodies in rheumatoid arthritis. Miossec P; Youinou P; Le Goff P; Moineau MP Clin Rheumatol; 1982 Sep; 1(3):185-9. PubMed ID: 6205812 [TBL] [Abstract][Full Text] [Related]
55. Anti-keratin antibodies in rheumatoid arthritis. Young BJ; Mallya RK; Leslie RD; Clark CJ; Hamblin TJ Br Med J; 1979 Jul; 2(6182):97-9. PubMed ID: 111762 [TBL] [Abstract][Full Text] [Related]
56. Prospect for an additional laboratory criterion for rheumatoid arthritis. von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480 [TBL] [Abstract][Full Text] [Related]
57. Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis. Zhou J; Dai Y; Lin Y; Chen K Semin Arthritis Rheum; 2022 Feb; 52():151943. PubMed ID: 35027248 [TBL] [Abstract][Full Text] [Related]